Short Report
Interactions between N–acetylcysteine and sodium selenite in modulating the clastogenicity of urethane and 2–acetylaminofluorene in mice
Roumen M. Balansky,
Silvio De Flora,
Roumen M. Balansky
National Center of Oncology, Sofia, Bulgaria
Search for more papers by this authorCorresponding Author
Silvio De Flora
Department of Health Sciences, University of Genoa, Genoa, Italy
Fax: +39-010-353-8504
Department of Health Sciences, University of Genoa, Via A. Pastore 1, I–16132 Genoa, ItalySearch for more papers by this authorRoumen M. Balansky,
Silvio De Flora,
Roumen M. Balansky
National Center of Oncology, Sofia, Bulgaria
Search for more papers by this authorCorresponding Author
Silvio De Flora
Department of Health Sciences, University of Genoa, Genoa, Italy
Fax: +39-010-353-8504
Department of Health Sciences, University of Genoa, Via A. Pastore 1, I–16132 Genoa, ItalySearch for more papers by this authorAbstract
Combined treatment with different agents represents a promising approach in cancer chemoprevention. Therefore, it is useful to assess in preclinical models the efficacy of combinations that are selected by taking into account mechanistic considerations. We designed 2 studies evaluating the interaction between N–acetylcysteine (NAC) and sodium selenite (Se), both given with the drinking water to Balb/c mice, in modulating clastogenic effects in bone marrow polychromatic erythrocytes. In a first study, a single i.p. injection of urethane considerably enhanced the frequency of micronucleated cells. While NAC produced a significant inhibition, Se further enhanced urethane clastogenicity. When given in combination at the same doses, NAC prevented the adverse effect of Se. In a second study, a single i.p. injection of 2–acetylaminofluorene enhanced the frequency of micronucleated cells. Se did not reduce this effect to a significant extent, while NAC produced a dose–dependent inhibition. When tested at the lower dose in combination with Se, the protective effect of NAC was unchanged. Especially in association with Se, NAC also prevented the toxicity of 2–acetylaminofluorene by normalizing the ratio of polychromatic to normochromatic erythrocytes. In conclusion, NAC attenuated the clastogenicity of both urethane and 2–acetylaminofluorene and the toxicity of this aromatic amine. In addition, NAC prevented the clastogenic and toxic effects resulting from the interaction of Se with urethane. Together with the findings of previous studies, it appears that, besides its intrinsic protective properties in carcinogenesis, NAC is capable of attenuating the adverse effects of several cytotoxic drugs and chemopreventive agents. © 2003 Wiley-Liss, Inc.
REFERENCES
- 1 Gupta RA, Dubois RN. Combinations for cancer prevention. Nat Med 2000; 6: 974–5.
- 2 De Flora S, Izzotti A, D'Agostini F, Balansky RM, Noonan D, Albini A. Multiple points of intervention in the prevention of cancer and other mutation related diseases. Mutat Res 2001; 480–1: 9–22.
- 3 Ip C. Feasibility of using lower doses of chemopreventive agents in a combination regimen for cancer protection. Cancer Lett 1988; 39: 239–46.
- 4 Kelloff GJ, Crowell JA, Boone CW, Steele VE, Lubet RA, Greenwald P, Alberts DS, Covey JM, Doodly LA, Knapp GG, Nayfield S, Parkinson DR, Prasad VK, Prorok PC, Sausville EA, Sigman CC. Strategy and planning for chemopreventive drug development: clinical development plans. J Cell Biochem 1994; 20(Suppl): 55–299.
- 5 De Flora S, Balansky R, Bennicelli C, Camoirano A, D'Agostini F, Izzotti A, Cesarone CF. Mechanisms of anticarcinogenesis: the example of N-acetylcysteine. In: C Ioannides, DFV Lewis, eds. Drugs, diet and disease, vol. 1, mechanistic approaches to cancer. Hemel Hempstead, UK: Ellis Horwood, 1995. 151–203.
- 6 De Flora S, Izzotti A, D'Agostini F, Balansky RM. Mechanisms of N–acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking–related end–points. Carcinogenesis 2001; 22: 999–1013.
- 7 De Flora S, Izzotti A, Albini A, D'Agostini F, Bagnasco M, Balansky RM. Antigenotoxic and cancer preventive mechanisms of N–acetyl–L–cysteine. In: GJ Kelloff, ET Hawk, CC Sigman, eds. Cancer chemoprevention, vol. 1, promising cancer chemopreventive agents. Totowa, NJ: Humana Press (in press).
- 8 Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman, DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973; 179: 588–90.
- 9 Schrauzer GN. Selenium. Mechanistic aspects of anricarcinogenic action. Biol Trace Elem Res 1992; 33: 51–62.
- 10 Ganther HE. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis 1999; 20: 1657–66.
- 11 El–Bayoumy K. The protective role of selenium on genetic damage and on cancer. Mutat Res 2001; 457: 123–39.
- 12 Ip C, Dong Y, Ganther HE. New concepts in selenium chemoprevention. Cancer Metastasis Rev 2002; 21: 281–9.
- 13 Izzotti A, Balansky RM, Cartiglia C, Camoirano A, Longobardi M, De Flora S. Genomic and transciptional alterations in mouse fetus liver after transplacental exposure to cigarette smoke. FASEB J 2003; 17: U126–9.
- 14 Rojas E, Herrera LA, Poirier LA, Ostrosky–Wegman P. Are metals dietary carcinogens? Mutat Res 1999; 443: 157–81.
- 15 Vinceti M, Wei E–T, Malagoli C, Bergomi M, Vivoli G. Adverse health effects of selenium in humans. Rev Environ Health 2001; 16: 233–51.
- 16 Balansky R. Comutagenic and coclastogenic effects of selenium in vitro and in vivo. Mutat Res 1991; 263: 231–6.
- 17 Schmid W. The micronucleus test. Mutat Res 1975; 31: 9–15.
- 18 Heddle J, Hite M, Kirkhart B, Mavournin K, MacGregor J, Newell G, Salomone M. The induction of micronuclei as a measure of genotoxicity. Mutat Res 1983; 123: 61–118.
- 19 El–Bayoumy K, Upadhyaya P, Chae YH, Sohn OS, Rao CV, Fiala E, Reddy BS. Chemoprevention of cancer by organoselenium compounds. J Cell Biochem 1995; 22(Suppl): 92–100.
- 20 De Flora S, Astengo M, Serra D, Bennicelli C. Inhibition of urethan-induced lung tumors in mice by dietary N-acetylcysteine. Cancer Lett 1986; 32: 235–41.
- 21
Balansky RM,
De Flora S.
Chemoprevention by N–acetylcysteine of urethane–induced lung tumors in mice, as related to the time–course monitoring of micronuclei in peripheral blood erythrocytes.
Int J Cancer
1998;
77:
302–5.
10.1002/(SICI)1097-0215(19980717)77:2<302::AID-IJC21>3.0.CO;2-B CAS PubMed Web of Science® Google Scholar
- 22 D'Agostini F, Balansky RM, Camoirano A, De Flora S. Interactions between N-acetylcysteine and ascorbic acid in modulating mutagenesis and carcinogenesis. Int J Cancer 2000; 88: 702–7.
- 23 Cesarone CF, Scarabelli L, Orunesu M, Bagnasco M, De Flora S. Effects of aminothiols in 2-acetylaminofluorene-treated rats: I, damage and repair of liver DNA, hyperplastic foci, and Zymbal gland tumors. In Vivo 1987; 1: 85–91.
- 24 Cesarone CF, Romano M, Serra D, Scarabelli L, De Flora S. Effects of aminothiols in 2-acetylaminofluorene-treated rats: II, glutathione cycle and liver cytosolic activities. In Vivo 1987; 1: 93–100.
- 25 De Flora S, Camoirano A, Bennicelli C, Orunesu M, Cesarone CF. Effects of aminothiols in 2-acetylaminofluorene-treated rats: III, metabolic activation of aromatic amines. In Vivo 1987; 1: 101–7.
- 26 Izzotti A, D'Agostini F, Bagnasco M, Scatolinini L, Rovida A, Balansky RM, Cesarone CF, De Flora S. Chemoprevention of carcinogen-DNA adducts and chronic degenerative diseases. Cancer Res 1994; 54: 1994S–8S.
- 27 Balansky R, Izzotti A, Scatolini L, D'Agostini F, De Flora S. Induction by carcinogens and chemoprevention by N–acetylcysteine of adducts to mitochondrial DNA in rat organs. Cancer Res 1996; 56: 1642–7.
- 28 Marshall MV, Arnott MS, Jacobs MM, Griffin AC. Selenium effects on the carcinogenicity and metabolism of 2–acetylaminofluorene. Cancer Lett 1979; 7: 331–8.
- 29 Mukherjee B, Chosh S, Chatterjee M. Chemopreventive efficacy of selenomethionine and its role in the antioxidant defense system in 2–acetylaminofluorene–induced hepatocarcinogenesis in rats. J Exp Ther Oncol 1996; 1: 209–17.
- 30 Balansky R. Investigation of antiblastomogenic activities of some compounds modulating the metabolism of chemical carcinogens. PhD thesis. Laboratory of Chemical Carcinogenic Agents, Institute of Oncology, Sankt–Petersburg, Russia 1976.
- 31 Schrauzer GN. Selenium and cancer: a review. Bioinorg Chem 1976; 5: 275–81.
- 32 Shen H-M, Yang C-F, Liu J, Ong C-N. Dual role of glutathione in selenite–induced oxidative stress and apoptosis in human hepatoma cells. Free Rad Biol Med 2000; 28: 1115–24.
- 33 Balansky R, Argirova R. Sodium selenite inhibition of the reproduction of some oncogenic RNA–viruses. Experientia 1981; 37: 1194–5.
- 34 Seko Y, Imura N. Active oxygen generation as a possible mechanism of selenium toxicity. Biochem Environ Sci 1997; 10: 333–9.
- 35 Emonet N, Leccia MT, Favier A, Beani JC, Richard MJ. Thiols and selenium: protective effect on human skin fibroblasts exposed to UVA radiation. J Photochem Photobiol B 1997; 40: 84–90.
- 36 Cotgreave IA, Moldéus P. Lung protection by thiol-containing antioxidants. Bull Eur Physiopathol Respir 1987; 23: 275–7.
- 37 Cotgreave IA, Sandy MS, Berggren M, Moldéus PW, Smith MT. N–acetylcysteine and glutathione–dependent protective effect of PZ51 (Ebselen) against diquat–induced cytotoxicity in isolated hepatocytes. Biohem Pharmacol 1987; 36: 2899–904.
- 38 Shilo S, Aronis A, Komarnitsky R, Tirosh O. Selenite sensitizes mitochondrial permeability transition pore opening in vitro and in vivo: possible mechanisms for chemo-protection. Biochem J 2003; 370: 283–90.
- 39 Li J, Zou L, Shen T, Xu C–M, Zhang Z–M. Induction of apoptosis by sodium selenite in human acute promyelocytic leukemia NB4 cells: involvement of oxidative stress and mitochondria. J Trace Elem Med Biol 2003; 17: 19–26.
- 40 Fleming J, Ghose A, Harrison PR. Molecular mechanisms of cancer prevention by selenium compounds. Nutr Cancer 2001; 40: 42–9.
- 41 Doroshow JH, Locker JY, Ifrim I, Myers CE. Prevention of doxorubicin cardiac toxicity in the mouse by N–acetylcysteine. J Clin Invest 1981; 68: 1053–64.
- 42 Holoye PY, Duelge J, Hansen RM, Ritch PS, Anderson T. Prophylaxis of ifosfamide toxicity with oral acetylcysteine. Sem Oncol 1983; 10(Suppl 1): 66–71.
- 43 De Flora S, D'Agostini F, Masiello L, Giunciuglio D, Albini A. Synergism between N–acetylcysteine and doxorubicin in the prevention of tumorigenicity and metastasis in murine models. Int J Cancer 1996; 62: 842–8.
- 44 Jiao D, Smith TJ, Yang C–S, Pittman B, Deasi D, Amin S, Chung F–L. Chemopreventive activity of thiol coniugates of isothiocyanates for lung tumorigenesis. Carcinogenesis 1997; 18: 2143–7.
- 45 Yang Y–M, Conaway CC, Chiao JW, Wang C–X, Amin S, Whysner J, Dai W, Reinhardt J, Chung F–L. Inhibition of benzo(a)pyrene–induced lung tumorigenesis in A/J mice by dietary N–acetylcysteine coniugates of benzyl and phenethyl isothiocyanates during the postinitiation phase is associated with activation of mitogen–activated protein kinases and p53 activity and induction of apoptosis. Cancer Res 2002; 62: 2–7.
Citing Literature
